Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 6;86(9):5137-5144.
doi: 10.1097/MS9.0000000000002424. eCollection 2024 Sep.

Urothelial cancer: state of art in Ukraine and improvement pathways

Maksym Pikul  1   2 , Prokip Gordiichuk  2 , Eduard Stakhovsky  1
Affiliations

Urothelial cancer: state of art in Ukraine and improvement pathways

Maksym Pikul et al. Ann Med Surg (Lond). .

Abstract

Aim: This study aims to assess the effectiveness of urothelial cancer treatment in Ukraine, utilizing population-based data from the National Cancer Registry. The primary goal is to evaluate trends and approaches to therapy, with a focus on overall survival rates in patients with urothelial tumors.

Materials and methods: A retrospective cross-sectional analysis was conducted based on the National Cancer Registry, involving 12 698 patients (2008-2020) with urothelial tumors of the upper urinary tract (UTUC) and bladder cancer (BC) who underwent surgical treatment. Demographic indicators, surgical interventions, complications, and survival rates were analyzed.

Results: The average age for all patients was 70 years. The number of patients undergoing radical treatment was 1820 (15%) among BC and 573 (59%) among UTUC. The 30-day readmission rate was low for both, with a slightly higher preference for UTUC (2.3 vs. 4.6%). Whereas grade III or higher Cl-Dindo complications were seen in only 0.2% of cases. Notable findings include low frequency of neoadjuvant (7%) and adjuvant chemotherapy (28%) among patients with invasive urothelial carcinomas. Median eGFR for invasive UTUC before and after surgery was 63.2 and 51.4 ml/min, respectively (P=0.00054). The directly opposite trend was seen in BC-61.2 and 68.7 ml/min, respectively (P=0.0026).For BC, the overall survival rates by stages were: I-73%, II-49%, III-18%, and IV-11% (χ2=1807.207; P=0.000001). As for UTUC, the 5-year overall survival rates corresponded to the literature data, but there was a pronounced negative trend towards a decrease in this indicator after a 10-year period for all stages (χ2=146.298; P=0.000003).

Conclusion: The study emphasizes the importance of effective systemic treatments, adherence to treatment guidelines, and the need for multidisciplinary consultations among Ukrainian patients with urothelial cancer.

Keywords: bladder cancer; organ-sparing surgery; radical cystectomy; radical nephroureterectomy; upper tract urothelial cancer; urothelial cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest and no financial interest in preparing this article.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Figures

Figure 1
Figure 1
Overall survival of patients with bladder cancer by stages.
Figure 2
Figure 2
Overall survival of patients with UTUC by stages. UTUC, upper tract urothelial cancer.
Figure 3
Figure 3
Overall survival of patients with UTUC undergoing RNUE and OSS. OSS, organ-sparing surgery; RNUE, radical nephroureterectomy; UTUC, upper tract urothelial cancer.
Figure 4
Figure 4
Difference in patients survival between patients undergoing RNUE in Oncological Referent Center and Rest of Ukraine. NCIU, oncological referent center; RNUE, radical nephroureterectomy; RU, rest Ukraine; UTUC, upper tract urothelial cancer.
Figure 5
Figure 5
Comparison of survival between patients undergoing RCE and RNUE. RCE, radical cystectomy; RNUE, radical nephroureterectomy.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Oosterlinck W, Solsona E, van der Meijden AP, et al. . EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 2004;46:147–15. - PubMed
    1. Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 2000;164:1523–152. - PubMed
    1. Huang WC, Levey AS, Serio AM, et al. . Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006;7:735–740. - PMC - PubMed
    1. Go AS, Chertow GM, Fan D, et al. . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Eng J Med 2004;351:1296–130. - PubMed
    1. Lane BR, Smith AK, Larson BT, et al. . Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 2010;15:2967–297. - PubMed

LinkOut - more resources